NMN+ Nano (In Development)
NMN+ Nano is nano-encapsulated nicotinamide mononucleotide, formulated for stability and bioavailability as a NAD+ precursor.
Life Sciences Pipeline
Four nano-encapsulated formulations are in development, each chosen because the unencapsulated active has a documented delivery weakness. Nothing listed is on sale, and no product is registered or approved in any market. Availability depends on the regulatory pathway in each jurisdiction.
Pipeline programs
NMN+ Nano is encapsulated NMN, a NAD+ precursor that is hygroscopic and degrades in moisture and heat. NAC Nano is encapsulated N-acetylcysteine, which has oral bioavailability of about 6 to 10% and oxidizes to its disulfide. Glutathione Nano addresses glutathione, a tripeptide broken down by gut enzymes when swallowed. Vital Porphyrin Nano is a specialty program for a porphyrin-class active whose aggregation and light sensitivity limit conventional formats; details are shared with partners under confidentiality.
How programs advance
Each program moves through the same gates: formulation screening, encapsulation efficiency and particle size, accelerated and long-term stability, release in simulated gastric and intestinal fluids, then human pharmacokinetic or consumer studies where the pathway allows. A program only moves forward when the encapsulated form beats the unencapsulated active on the parameter that matters for that compound, whether that is shelf stability, gastric survival or plasma exposure. Programs that fail a gate are paused or reformulated, and partners see the data either way.
Professional Ampoules and licensing
Alongside the pipeline, white label and licensing partners can access professional-use application ampoules manufactured to GMP standards on the same delivery platform. Pipeline formulations are also available for licensing before launch, so a brand or distributor can take a program into its own markets under its own regulatory filings. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease.
Key facts
- Oral NAC bioavailability in humans is roughly 6 to 10% because of extensive first-pass metabolism (Borgstrom et al. 1986, Eur J Clin Pharmacol)
- A single 3 g oral dose of glutathione did not raise plasma glutathione in healthy volunteers (Witschi et al. 1992, Eur J Clin Pharmacol)
- FDA confirmed in 2025 that NMN may be marketed as a dietary supplement ingredient, subject to new dietary ingredient requirements (FDA response to Natural Products Association, 2025)
- FDA announced enforcement discretion for NAC in dietary supplements in 2022 while NAC remains an approved drug ingredient (FDA guidance, NAC in dietary supplements, 2022)
How our delivery technology applies
Each pipeline active fails differently, so each gets a different layer design. NMN needs a moisture barrier for shelf life. NAC and glutathione need oxidation protection in storage and shielding from gut peptidases. The porphyrin program needs a matrix that keeps molecules from stacking into aggregates and blocks light. Using one programmable platform lets us tune layer chemistry per active instead of forcing all four into one generic liposome.
License a pipeline program for your market.
NAC Nano (In Development)
NAC Nano is nano-delivered N-acetylcysteine for antioxidant and cellular support formulations.
Glutathione Nano (In Development)
Glutathione is notoriously degraded when taken orally, and a single oral dose does not reliably raise blood levels.
Vital Porphyrin Nano (In Development)
Vital Porphyrin Nano is a specialty nano-delivered active from the porphyrin class, the ring structures behind heme and chlorophyll.
Related reading
What 'in development' means here
Everything on this page is in development. Nothing listed is on sale, and the presence of a format here is not a claim that it is registered, approved or available in any market - where a product reaches launch it will appear with its own page, its own composition and the registrations that apply to it.
The pipeline exists because the encapsulation platform is not crop-specific. The same multi-layer biopolymer shell that protects an active on a leaf until conditions release it, and that carries actives into the upper layers of skin in the Beauty Science range, is the mechanism these formats are built on. What changes between the sciences is the active, the trigger and the format, not the underlying technology - which is why work proven in one science shortens the path in the next.
If you are a brand, a manufacturer or a distributor looking at one of these formats, the useful conversation is early. See Partnerships for how research and technical evaluation work, Technology for the platform itself, or contact us directly.
Last updated: